Latest News about GILD
Recent news which mentions GILD
S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What's Driving Markets Wednesday?
February 07, 2024
From Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $10,000 Today
February 07, 2024
From Benzinga
2 Beaten-Down Dividend Stocks to Buy Hand Over Fist
February 07, 2024
From Motley Fool
Gilead Sciences (GILD) Q4 2023 Earnings Call Transcript
February 06, 2024
Tickers
GILD
From Motley Fool
Why Gilead Sciences Stock Is Trading Lower After The Bell
February 06, 2024
From Benzinga
Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday?
February 06, 2024
From Benzinga
Earnings Scheduled For February 6, 2024
February 06, 2024
From Benzinga
3 Top Pharma Stocks to Buy Now: February 2024
February 01, 2024
From InvestorPlace
A New COVID-19 Variant Is Rapidly Spreading Around The Globe, Other Pandemic Threats Exist – What Are The Choices For Treatment?
January 31, 2024
From Benzinga
From Benzinga
From Benzinga
Behind the Scenes of Gilead Sciences's Latest Options Trends
January 25, 2024
Tickers
GILD
From Benzinga
Gilead's Tecartus Dropped From FDA List Of CAR-T Therapy With Updated Label Warning Of "Risks Of Secondary Cancer'
January 24, 2024
From Benzinga
From Benzinga
From Benzinga
7 Speculative Stocks to Double Your Money THIS Year
January 22, 2024
From InvestorPlace
S&P 500, Dow Extend All-Time Highs: 'It's A Lot Of Fun For Stock Investors While It Lasts,' Wall Street Veteran Says
January 22, 2024
From Benzinga
Dow Gains Over 100 Points; Archer-Daniels-Midland Shares Plunge
January 22, 2024
From Benzinga
S&P 500, Nasdaq, Dow Jones Strike All-Time Highs Ahead Of Key Earnings This Week: What's Driving Markets Monday?
January 22, 2024
From Benzinga
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 22, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 22, 2024
From Benzinga
From Benzinga
Why Is HIV Drug Giant Gilead Stock Falling Monday?
January 22, 2024
From Benzinga
EXCLUSIVE: The 'Buy Everything' Market Is Over: Synopsys-Ansys Merger Provides Fertile Ground For This Stock Picker
January 18, 2024
From Benzinga
From Benzinga
From Benzinga
AbbVie's Strategic Move: ImmunoGen Acquisition Triggers Golden Cross, Yet Valuation Caution Remains
January 11, 2024
From Benzinga
Gilead’s Quiet Revolution: Is GILD the Next Big Stock to Soar?
January 10, 2024
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.